Sign In
Labcorp Oklahoma, Inc.
Test Directory


Index:

Von Willebrand Factor Multimer Assay

Order Name VON W MULT
Test Number: 1502250
Revision Date 05/27/2026
Test Name Methodology LOINC Code
von Willebrand Factor Antigen
See Test Notes 27816-8 
von Willebrand Factor Activity
See Test Notes 107372-5 
von Willebrand Factor Activity/Ag
See Test Notes 81643-9 
Low Molecular Wt vWF
See Test Notes n/a 
Intermediate Molecular Wt vWF
See Test Notes n/a 
High Molecular Wt vWF
See Test Notes 52754-9 
von Willebrand Factor Interpretation
See Test Notes 48595-3 
SPECIMEN REQUIREMENTS
Specimen Specimen Volume (min) Specimen Type Specimen Container Transport Environment
Preferred 2 mL (1) Plasma Sodium Citrate 3.2% (Blue Top) Frozen
Instructions Plasma from Light Blue Top Tube - Frozen
Volume: 2.0mL (min 1.0mL Note: This volume does not allow for repeat testing.)
Container: Blue stopper 3.2% sodium citrate plasma evacuated tube
Collection: Blood should be collected in a blue-top tube containing 3.2% buffered sodium citrate.24 Evacuated collection tubes must be filled to completion to ensure a proper blood-to-anticoagulant ratio.25,26 The sample should be mixed immediately by gentle inversion at least six times to ensure adequate mixing of the anticoagulant with the blood. A discard tube is not required prior to collection of coagulation samples unless the sample is collected using a winged (butterfly) collection system. With a winged blood collection set, a discard tube should be drawn first to account for the dead space of the tubing and prevent under-filling of the evacuated tube.27,28 When noncitrate tubes are collected for other tests, collect sterile and nonadditive (red-top) tubes prior to citrate (blue-top) tubes. Any tube containing an alternative anticoagulant should be collected after the blue-top tube. Gel-barrier tubes and serum tubes with clot initiators should also be collected after the citrate tubes. Please print and use the Volume Guide for Coagulation Testing to ensure proper draw volume.
Cause for Rejection: Lipemia; icteric specimen; hemolysis; clotted specimen; specimen contaminated with heparin (i.e., drawn with blood gases)
GENERAL INFORMATION
Expected TAT 4 - 11 days  
Performing Labcorp Test Code 117245 
Notes The Sebia Hydragel™ assay employs an agarose gel for the separation of plasma proteins according to their molecular weight. The electrophoretic separation is carried out after sample treatment with an anionic detergent. This treatment disrupts the three-dimensional structure of the plasma VWF, allowing for the electrophoretic separation of the multimers based on their molecular weight. The system can reveal the loss or retention of HMWM and also intermediate MWM (IMWM) and thus serve as an aid in the characterization of the majority of VWD cases, for example, distinguishing samples with loss of HMWM (and potentially IMWM) (being type 2A, 2B or PT-VWD) from samples without loss of HMWM and/or IMWM (being type 1, 2M, 2N VWD or normal samples), from samples without VWF (i.e., type 3 VWD).1,2 von Willebrand Factor Antigen and Activity levels are measured in order to determine dilution needed for the multimer analysis and as an aid in interpretation of multimer pattern.
 
Result Code Result Name LOINC Code
5197557 von Willebrand Factor Antigen 27816-8
5197558 von Willebrand Factor Activity 107372-5
5197559 von Willebrand Factor Activity/Ag 81643-9
5197560 Low Molecular Wt vWF n/a
5197561 Intermediate Molecular Wt vWF n/a
5197562 High Molecular Wt vWF 52754-9
5197563 von Willebrand Factor Interp 48595-3
CPT Code(s) 85245, 85246, 85247
Lab Section Reference Lab